Search Results - Heinrich Roder
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
-
6
Development and validation of a serum proteomic test for predicting patient outcomes in advanced non-small cell lung cancer treated with atezolizumab or docetaxel by Joanna Roder, Heinrich Roder, Senait Asmellash, Wei Zou, Mark McCleland, Laura Maguire, Patrick Norman, Lelia Net, Robert Georgantas, Minu K Srivastava, David S Shames
Published in Journal for ImmunoTherapy of Cancer (2025-05-01)Get full text
Article -
7
26 Validation of the Primary Immune Response (PIR) test in advanced non-small cell lung cancer (NSCLC): blinded retrospective analyses from the POPLAR and OAK trials by Joanna Roder, Heinrich Roder, Senait Asmellash, Minu Srivastava, Wei Zou, Mark McCleland, David Shames, Laura Maguire, Steven Rightmyer, Patrick Norman, Lelia Net, Thomas Campbell, Robert Georgantas
Published in Journal for ImmunoTherapy of Cancer (2021-11-01)Article -
8
Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidance by Matthew A. Koc, Timothy Aaron Wiles, Daniel C. Weinhold, Steven Rightmyer, Amanda L. Weaver, Colin T. McDowell, Joanna Roder, Senait Asmellash, Gary A. Pestano, Heinrich Roder, Robert W. Georgantas III
Published in Journal of Mass Spectrometry and Advances in the Clinical Lab (2023-11-01)Get full text
Article -
9
Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lu... by Alessandra I. G. Buma, Berber Piet, Rob ter Heine, Michel M. van den Heuvel, Paul Brinkman, Daan van den Broek, Sjaak Burgers, Francesco Ciompi, Simona M. Cristescu, Bram van Ginneken, Katrien Grünberg, Lizza Hendriks, Jeroen Hiltermann, Firdaus Mohamed Housein, Alwin Huitema, Jakko van Inge, Colin Jacobs, Hans Koenen, Marjolijn Ligtenberg, Anke H. Maitland-van der Zee, Vincent van der Noort, Mathias Prokop, Valesca Rètel, Heinrich Roder, Huub van Rossum, Ruben Smeets, Thomas Würdinger
Published in Frontiers in Pharmacology (2023-11-01)Get full text
Article
